Many objections had risen regarding this new ruling. Therefore, this policy has been reviewed in 2005 by the Ministry of Health after complains from pharmaceutical companies and members of the Parliament.

According to this new regulation, the trademark and the generic name will be both indicated on each packaging, now the trademark being above the generic name. The writing of the latter shall be at least 80 % of the size of the trademark, with same color and font like the trademark.

Pharmaceutical companies have a six-month grace period to comply with this new regulation.

The Indonesian Ministry of Health has informed that the purpose of the regulation is to improve generic drug consumption and public's reliance to generic medicines. The inclusion of the generic name on the packaging is a way to provide accurate information to patients.